We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
 
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Sticky Logo
Woman holding up a plastic model of a molecule Woman holding up a plastic model of a molecule

Publications

Discover our latest research

Follow us as we translate our deep expertise in structure-based drug discovery into novel, selective therapeutics that enable durable responses for patients with cancer.

All ROS1 NSCLC ALK NSCLC HER2 NSCLC
Load More

Patient impact drives solutions

Patient impact drives solutions

Our goal is to develop new therapies that have the potential for real Patient Impact. By applying innovative chemistry to overcoming challenging medical needs, we aim to develop precisely targeted solutions with the potential to drive deep and durable responses for patients with cancer.”

James R. Porter, PhD

Chief Executive Officer
Molecule shape
One Broadway 14th Floor Cambridge, MA 02142 (857) 357-7000
CONTACT US

©2025 Nuvalent. All rights reserved.

You are about to leave the Nuvalent website.

Nuvalent does not endorse or take responsibility for any information or statements made on external sites.

Do you wish to continue?

Cancel Continue